8-103403276-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3PP5

The NM_030780.5(SLC25A32):​c.440G>A​(p.Arg147His) variant causes a missense change. The variant allele was found at a frequency of 0.000171 in 1,612,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00017 ( 0 hom. )

Consequence

SLC25A32
NM_030780.5 missense

Scores

13
5
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:2

Conservation

PhyloP100: 5.56

Publications

11 publications found
Variant links:
Genes affected
SLC25A32 (HGNC:29683): (solute carrier family 25 member 32) This gene encodes a member of the P(I/L)W subfamily of mitochondrial carrier family transport proteins. The encoded protein transports folate across the inner mitochondrial membrane. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2013]
SLC25A32 Gene-Disease associations (from GenCC):
  • exercise intolerance, riboflavin-responsive
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.823
PP5
Variant 8-103403276-C-T is Pathogenic according to our data. Variant chr8-103403276-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 223106.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC25A32NM_030780.5 linkc.440G>A p.Arg147His missense_variant Exon 4 of 7 ENST00000297578.9 NP_110407.2 Q9H2D1
SLC25A32NR_102337.2 linkn.524G>A non_coding_transcript_exon_variant Exon 3 of 6
SLC25A32NR_102338.2 linkn.719G>A non_coding_transcript_exon_variant Exon 5 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC25A32ENST00000297578.9 linkc.440G>A p.Arg147His missense_variant Exon 4 of 7 1 NM_030780.5 ENSP00000297578.4 Q9H2D1
ENSG00000285982ENST00000649416.1 linkc.287G>A p.Arg96His missense_variant Exon 6 of 9 ENSP00000496817.1 A0A3B3IRK5

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
151812
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000315
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000716
AC:
18
AN:
251262
AF XY:
0.0000589
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000168
AC:
245
AN:
1460314
Hom.:
0
Cov.:
30
AF XY:
0.000168
AC XY:
122
AN XY:
726560
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33438
American (AMR)
AF:
0.0000224
AC:
1
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39646
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86114
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53360
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.000207
AC:
230
AN:
1110874
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
151926
Hom.:
0
Cov.:
31
AF XY:
0.000215
AC XY:
16
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.000314
AC:
13
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4798
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10496
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
67970
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000212
Hom.:
0
Bravo
AF:
0.000223
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.0000906
AC:
11

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Exercise intolerance, riboflavin-responsive Pathogenic:2
Oct 12, 2020
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Aug 24, 2021
MGZ Medical Genetics Center
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Dec 15, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SLC25A32 c.440G>A (p.Arg147His) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.2e-05 in 251262 control chromosomes (gnomAD). c.440G>A has been reported in the literature in an individual affected with Exercise Intolerance, Riboflavin-Responsive who was compound heterozygous with a truncating variant (Schiff_2016). These data do not allow any conclusion about variant significance. This publication also reports experimental evidence evaluating an impact on protein function in a yeast model, finding that the missense variant in the orthologous protein results in significantly reduced enzymatic activity. The following publication has been ascertained in the context of this evaluation (PMID: 26933868). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified it as pathogenic (n=1), likely pathogenic (n=1), or uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -

not provided Uncertain:1
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 147 of the SLC25A32 protein (p.Arg147His). This variant is present in population databases (rs142329098, gnomAD 0.04%). This missense change has been observed in individual(s) with recurrent exercise intolerance (PMID: 26933868). ClinVar contains an entry for this variant (Variation ID: 223106). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SLC25A32 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC25A32 function (PMID: 26933868). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Pathogenic
0.41
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.65
D;.
Eigen
Pathogenic
0.87
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Pathogenic
0.82
D;D
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Pathogenic
3.8
H;.
PhyloP100
5.6
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-4.9
D;.
REVEL
Pathogenic
0.89
Sift
Pathogenic
0.0
D;.
Sift4G
Pathogenic
0.0
D;.
Polyphen
1.0
D;.
Vest4
0.96
MVP
1.0
MPC
1.2
ClinPred
0.98
D
GERP RS
5.0
Varity_R
0.95
gMVP
0.91
Mutation Taster
=13/87
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142329098; hg19: chr8-104415504; COSMIC: COSV52567293; COSMIC: COSV52567293; API